 Veru Inc NASDAQ: VERU shares are trading significantly higher Monday after the company reported its novel COVID-19 drug candidate reduced deaths by 55 in hospitalized patients in an interim analysis of the Phase 3 study. The study evaluated the companys oral COVID-19 candidate. 